肩峰下皮质类固醇注射治疗2型糖尿病的疗效和安全性。

Q2 Medicine
Pain Research and Treatment Pub Date : 2018-09-20 eCollection Date: 2018-01-01 DOI:10.1155/2018/9279343
Davide Blonna, Davide Edoardo Bonasia, Lorenzo Mattei, Enrico Bellato, Valentina Greco, Roberto Rossi
{"title":"肩峰下皮质类固醇注射治疗2型糖尿病的疗效和安全性。","authors":"Davide Blonna,&nbsp;Davide Edoardo Bonasia,&nbsp;Lorenzo Mattei,&nbsp;Enrico Bellato,&nbsp;Valentina Greco,&nbsp;Roberto Rossi","doi":"10.1155/2018/9279343","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>In type 2 diabetic patients affected by chronic shoulder pain, subacromial injection with corticosteroid could be an effective treatment. The aim of this study was to measure the risk-benefit ratio of this treatment.</p><p><strong>Methods: </strong>Twenty patients with well-controlled diabetes were included in a prospective study. In a first preinjection phase, patients were asked to measure glycemia for 7 days, before breakfast and dinner, and then 2 hours after lunch and dinner. Baseline data including Constant Score (CS), Subjective Shoulder Value (SSV), and Numerical Rating Scale (NRS) for pain were collected. Patients were treated with subacromial injection with 40 mg of Methylprednisolone Acetate and 2 ml of Lidocaine. At discharge, patients were asked to remeasure glycemia for the following week.</p><p><strong>Results: </strong>The overall pain improved and patients graded their shoulder as \"greatly improved\". At 30-day follow-up, the SSV and the CS improved, considering pain but not ROM. The average daily glycemia was 136 mg/dl before injection, 161 mg/dl the day of the injection (p<0.001), and 170 mg/dl one day after injection (p<0.001). Glycemia was not statistically different 3 days after injection.</p><p><strong>Conclusion: </strong>Subacromial injection is an effective short-term treatment in type 2 diabetic patients affected by shoulder pain, but a closed follow-up is recommended in all these patients. This trial is registered with NCT03652480. The Protocol ID is SHOULDERDM2013.</p>","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/9279343","citationCount":"5","resultStr":"{\"title\":\"Efficacy and Safety of Subacromial Corticosteroid Injection in Type 2 Diabetic Patients.\",\"authors\":\"Davide Blonna,&nbsp;Davide Edoardo Bonasia,&nbsp;Lorenzo Mattei,&nbsp;Enrico Bellato,&nbsp;Valentina Greco,&nbsp;Roberto Rossi\",\"doi\":\"10.1155/2018/9279343\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>In type 2 diabetic patients affected by chronic shoulder pain, subacromial injection with corticosteroid could be an effective treatment. The aim of this study was to measure the risk-benefit ratio of this treatment.</p><p><strong>Methods: </strong>Twenty patients with well-controlled diabetes were included in a prospective study. In a first preinjection phase, patients were asked to measure glycemia for 7 days, before breakfast and dinner, and then 2 hours after lunch and dinner. Baseline data including Constant Score (CS), Subjective Shoulder Value (SSV), and Numerical Rating Scale (NRS) for pain were collected. Patients were treated with subacromial injection with 40 mg of Methylprednisolone Acetate and 2 ml of Lidocaine. At discharge, patients were asked to remeasure glycemia for the following week.</p><p><strong>Results: </strong>The overall pain improved and patients graded their shoulder as \\\"greatly improved\\\". At 30-day follow-up, the SSV and the CS improved, considering pain but not ROM. The average daily glycemia was 136 mg/dl before injection, 161 mg/dl the day of the injection (p<0.001), and 170 mg/dl one day after injection (p<0.001). Glycemia was not statistically different 3 days after injection.</p><p><strong>Conclusion: </strong>Subacromial injection is an effective short-term treatment in type 2 diabetic patients affected by shoulder pain, but a closed follow-up is recommended in all these patients. This trial is registered with NCT03652480. The Protocol ID is SHOULDERDM2013.</p>\",\"PeriodicalId\":19786,\"journal\":{\"name\":\"Pain Research and Treatment\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2018/9279343\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pain Research and Treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2018/9279343\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2018/9279343","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 5

摘要

目的:2型糖尿病合并慢性肩痛患者,肩峰下注射皮质类固醇是一种有效的治疗方法。本研究的目的是衡量这种治疗的风险-收益比。方法:对20例控制良好的糖尿病患者进行前瞻性研究。在第一个注射前阶段,患者被要求测量血糖7天,在早餐和晚餐前,然后在午餐和晚餐后2小时。基线数据包括疼痛的恒定评分(CS)、主观肩值(SSV)和数值评定量表(NRS)。患者在肩峰下注射40 mg醋酸甲基强的松龙和2 ml利多卡因。出院时,要求患者在接下来的一周内重新测量血糖。结果:整体疼痛得到改善,患者将肩部评分为“极大改善”。在30天的随访中,SSV和CS改善,考虑疼痛而不考虑ROM。注射前平均每日血糖为136 mg/dl,注射当天为161 mg/dl。结论:肩峰下注射是2型糖尿病肩关节疼痛患者的有效短期治疗方法,但所有患者都建议进行封闭随访。该试验注册号为NCT03652480。协议ID为SHOULDERDM2013。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Efficacy and Safety of Subacromial Corticosteroid Injection in Type 2 Diabetic Patients.

Efficacy and Safety of Subacromial Corticosteroid Injection in Type 2 Diabetic Patients.

Efficacy and Safety of Subacromial Corticosteroid Injection in Type 2 Diabetic Patients.

Efficacy and Safety of Subacromial Corticosteroid Injection in Type 2 Diabetic Patients.

Purpose: In type 2 diabetic patients affected by chronic shoulder pain, subacromial injection with corticosteroid could be an effective treatment. The aim of this study was to measure the risk-benefit ratio of this treatment.

Methods: Twenty patients with well-controlled diabetes were included in a prospective study. In a first preinjection phase, patients were asked to measure glycemia for 7 days, before breakfast and dinner, and then 2 hours after lunch and dinner. Baseline data including Constant Score (CS), Subjective Shoulder Value (SSV), and Numerical Rating Scale (NRS) for pain were collected. Patients were treated with subacromial injection with 40 mg of Methylprednisolone Acetate and 2 ml of Lidocaine. At discharge, patients were asked to remeasure glycemia for the following week.

Results: The overall pain improved and patients graded their shoulder as "greatly improved". At 30-day follow-up, the SSV and the CS improved, considering pain but not ROM. The average daily glycemia was 136 mg/dl before injection, 161 mg/dl the day of the injection (p<0.001), and 170 mg/dl one day after injection (p<0.001). Glycemia was not statistically different 3 days after injection.

Conclusion: Subacromial injection is an effective short-term treatment in type 2 diabetic patients affected by shoulder pain, but a closed follow-up is recommended in all these patients. This trial is registered with NCT03652480. The Protocol ID is SHOULDERDM2013.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pain Research and Treatment
Pain Research and Treatment Medicine-Anesthesiology and Pain Medicine
CiteScore
3.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信